US OptionsDetailed Quotes
TGTX250502C46500
- 0.05
- -0.25-83.33%
15min DelayClose May 2 16:00 ET
0.10High0.05Low
0.10Open0.30Pre Close41 Volume31 Open Interest46.50Strike Price405.00Turnover1509.53%IV7.16%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0638Delta0.0683Gamma868.80Leverage Ratio-38.9920Theta0.0000Rho55.44Eff Leverage0.0002Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet